EMA Says Sinus Bradycardia a Possible Risk With Remdesivir EMA Says Sinus Bradycardia a Possible Risk With Remdesivir

A causal relationship between COVID-19 treatment with remdesivir and sinus bradycardia is ' at least a reasonable possibility, ' the EMA ' s safety committee has concluded.News Alerts
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Cardiology News Alert Source Type: news